Dixon Hubard Feinour & Brown’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $890K | Hold |
20,218
| – | – | 0.11% | 153 |
|
2022
Q1 | $806K | Buy |
20,218
+200
| +1% | +$7.97K | 0.08% | 175 |
|
2021
Q4 | $805K | Buy |
20,018
+1,050
| +6% | +$42.2K | 0.08% | 170 |
|
2021
Q3 | $772K | Buy |
18,968
+5,000
| +36% | +$204K | 0.16% | 94 |
|
2021
Q2 | $634K | Sell |
13,968
-13,968
| -50% | -$634K | 0.13% | 106 |
|
2021
Q1 | $949K | Buy |
27,936
+13,968
| +100% | +$475K | 0.12% | 114 |
|
2020
Q4 | $367K | Hold |
13,968
| – | – | 0.09% | 119 |
|
2020
Q3 | $367K | Hold |
13,968
| – | – | 0.09% | 119 |
|
2020
Q2 | $380K | Hold |
13,968
| – | – | 0.1% | 114 |
|
2020
Q1 | $251K | Hold |
13,968
| – | – | 0.08% | 134 |
|
2019
Q4 | $248K | Hold |
13,968
| – | – | 0.06% | 155 |
|
2019
Q3 | $217K | Sell |
13,968
-1,794
| -11% | -$27.9K | 0.06% | 163 |
|
2019
Q2 | $271K | Sell |
15,762
-940
| -6% | -$16.2K | 0.08% | 146 |
|
2019
Q1 | $269K | Hold |
16,702
| – | – | 0.08% | 143 |
|
2018
Q4 | $244K | Hold |
16,702
| – | – | 0.09% | 134 |
|
2018
Q3 | $303K | Hold |
16,702
| – | – | 0.08% | 134 |
|
2018
Q2 | $282K | Sell |
16,702
-535
| -3% | -$9.03K | 0.08% | 135 |
|
2018
Q1 | $338K | Hold |
17,237
| – | – | 0.09% | 138 |
|
2017
Q4 | $349K | Sell |
17,237
-707
| -4% | -$14.3K | 0.09% | 139 |
|
2017
Q3 | $312K | Hold |
17,944
| – | – | 0.09% | 142 |
|
2017
Q2 | $230K | Hold |
17,944
| – | – | 0.07% | 160 |
|
2017
Q1 | $233K | Hold |
17,944
| – | – | 0.07% | 155 |
|
2016
Q4 | $177K | Hold |
17,944
| – | – | 0.06% | 164 |
|
2016
Q3 | $217K | Buy |
+17,944
| New | +$217K | 0.07% | 160 |
|